Management of foot/ankle osteoarthritis by Australian general practitioners: an analysis of national patient-encounter records
KL Paterson, C Harrison, H Britt, RS Hinman, KL Bennell
Osteoarthritis and Cartilage | ELSEVIER SCI LTD | Published : 2018
Awarded by NHMRC
Awarded by Australian Research Council Future Fellowship
This study was supported by a NHMRC Program Grant (#1091302). KB is partly funded by the National Health and Medical Research Council (NHMRC) and RH is supported by an Australian Research Council Future Fellowship (FT130100175). Between 2010 and 2016 the BEACH program was funded by: AbbVie Pty Ltd, Australian Government Department of Health, Australian Government Department of Veterans' Affairs, AstraZeneca Pty Ltd (Australia), Bayer Australia Ltd, bioCSL (Australia), GlaxoSmithKline Australia Pty Ltd, Merck, Sharp and Dohme (Australia), National Prescribing Service Ltd, Novartis Pharmaceuticals Australia Pty Ltd, Sanofi-Aventis Australia Pty Ltd, Seqirus (Australia) Pty Ltd and Pfizer Australia. The funding bodies had no influence on the conceptualisation, design or conduct of the research, nor on the preparation of this paper.